Rocket


Overview
Financials
News + Filings
Key Docs
Ownership





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ADC Therapeutics SA

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   20-F20-F20-F20-F20-F
Condensed Income Statement [Table]       
Condensed Income Statements, Captions [Line Items]       
Total revenue       
Cost of product sales       
Research and development expenses       
Selling and marketing expenses       
General and administrative expenses       
Total operating expense       
    Loss from operations       
Other income (expense)       
Financial income       
Financial expense       
    Total other (expense) income     -1.4 
   
    Loss before taxes       
Income tax benefit       
    Net loss       
Net loss attributable to:       
Owners of the parent       
Net loss per share       
Net loss per share, basic (in USD per share)       
Net loss per share, diluted (in dollars per share)       

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy